BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Theravance Narrows Focus to Multiple System Atrophy Subset Following Mixed Results from the Ampreloxetine Study

  Theravance Biopharma announced mixed results from a study evaluating the use of ampreloxetine to reduce symptomatic neurogenic orthostatis hypotension (nOH).

  April 5, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano M.S.
• 

  Policy

  COVID-19 Update: Senate Agrees to $10B in Funding, Moderna CEO Talks Boosters

  Stephane Bancel, the chief executive of Moderna, has likened the need for booster vaccine doses to the way Apple releases new smartphones every year.

  April 5, 2022

   · 

  4 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Argenx, Pharma Two B, SanBio Present at AAN

  Discover what’s in store for today’s presentations at The American Academy of Neurology’s annual meeting, which will include data for a variety of neurological treatments.

  April 5, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Genetown

  First-Ever Computationally-Designed Antibody Enters Clinical Trials

  Biolojic Design announced that the first-ever computationally-designed human antibody will enter the clinic. The company will study AU-007 in solid cancer tumors.

  April 5, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Celeris Reels in Another Big Partner in Boehringer Ingelheim

  Celeris Therapeutics and Boehringer Ingelheim (BI) have announced they are entering into a collaboration to develop next-generation targeted protein degraders.

  April 5, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Policy

  BMS-Sponsored Diversity in Oncology Series Tackles Representation in Clinical Trials

  BMS partnered with digital oncology company GRYT Health to convene a series of “courageous conversations” between patients, practitioners, caregivers, clinical trial teams and public health leaders.

  April 5, 2022

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Career Advice

  How and Why Employees with Disabilities Can Ask for Accommodations

  Requesting disability accommodations is vital for your success in the workplace. You can find out everything about how to ask for accommodations in our guide.

  April 5, 2022

   · 

  4 min read

   · 

  Franklin Carpenter
• 

  Business

  Feeling Blue: bluebird bio Cuts Staff by 30%, Prepares for FDA Decision

  Following the ongoing trend in the pharmaceutical industry, approximately 30% of bluebird’s staff will be let go in an effort to reduce operational costs to under $340 million by the end of 2022.

  April 5, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Drug Development

  Wave ALS Update Delights Industry Observers, Investors

  The company’s shares rose by 29.6% on NASDAQ shortly after the announcement.

  April 5, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  5AM Ventures Pumps Another $750 Million into Life Sciences Industry

  With the close of these two funds, Andrew Schwab, managing partner at 5AM Ventures, said the firm has raised more than $2.2 billion to invest in the life sciences industry.

  April 5, 2022

   · 

  2 min read

   · 

  Alex Keown